| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/14/2011 | WO2011084816A1 Leucine/peptide composition and method of formulation |
| 07/14/2011 | WO2011084808A2 Bifunctional polypeptide compositions and methods for treatment of metabolic and cardiovascular diseases |
| 07/14/2011 | WO2011084749A1 Compositions and methods for inhibiting mmp-9-mediated cell migration |
| 07/14/2011 | WO2011084685A2 Saposin-a derived peptides and uses thereof |
| 07/14/2011 | WO2011084548A2 Methods and compositions for detecting recesssive familial fsgs and uses thereof |
| 07/14/2011 | WO2011084479A1 Substance p and analogs thereof as adjuvant therapy for adoptive cellular immunotherapy |
| 07/14/2011 | WO2011084452A1 Therapeutic uses of soluble alpha-klotho |
| 07/14/2011 | WO2011084451A2 Methods and compositions for liquidation of tumors |
| 07/14/2011 | WO2011084061A1 Cpp (cell penetrating peptide) and its uses |
| 07/14/2011 | WO2011083483A2 Method for treatment of inflammatory disease and disorder |
| 07/14/2011 | WO2011083482A2 Method for treatment of psoriasis |
| 07/14/2011 | WO2011083481A2 Method for treatment of inflammatory disease and disorder |
| 07/14/2011 | WO2011083473A1 Volatile organic compounds as diagnostic markers for various types of cancer |
| 07/14/2011 | WO2011083317A1 Ev576 for use in the treatment of viral infections of the respiratory tract |
| 07/14/2011 | WO2011083154A1 Dry powder fibrin sealant |
| 07/14/2011 | WO2011083153A2 Fibrinogen preparations enriched in fibrinogen with an extended alpha chain |
| 07/14/2011 | WO2011083147A1 Wave1 inhibition in the medical intervention of inflammatory diseases and/or infections caused by a pathogen |
| 07/14/2011 | WO2011082951A1 Combination preparations comprising a cytokine antagonist and corticosteroid |
| 07/14/2011 | WO2011082950A1 Combination preparations comprising exosomes and corticosteroid |
| 07/14/2011 | WO2011082458A1 Adjuvant immunotherapy for the preventive, curative or palliative treatment of chronic systemic diseases such as cancer, of clinical manifestations associated with these diseases, such as cachexia, and remedying adverse effects of drugs and treatments, such as immunodepression, neutropenia and lymphocytopenia, comprising the association or combination of a specially selected biological response modifier and other antineoplastic compounds and/or other treatments |
| 07/14/2011 | WO2011061700A3 Ifnϒ inhibitors in the treatment of motoneuron diseases |
| 07/14/2011 | WO2011061376A3 Use of cd98 as endometrial receptivity marker |
| 07/14/2011 | WO2011054001A8 Analogs of pitutary adenylate cyclase-activating polypeptide (pacap) and methods for their use |
| 07/14/2011 | WO2011049289A3 Polypeptide or fused protein thereof inhibiting the extravasation of white blood cells or the growth and/or metastasis of cancer cells |
| 07/14/2011 | WO2011036326A3 Novel recombinant proteinic polymers and method for bioactivating surfaces with said polymers |
| 07/14/2011 | WO2011033358A3 Novel peptides isolated from spider venom, and uses thereof |
| 07/14/2011 | WO2011031460A3 Novel anti-inflammatory peptides that bind oxidized phospholipids |
| 07/14/2011 | WO2011028813A3 Insulin analogues of enhanced receptor-binding specificity |
| 07/14/2011 | WO2011028485A3 Tumoricidal, bactericidal, or viricidal macrophage activation |
| 07/14/2011 | WO2011028064A3 Novel bacteriophage and antibacterial composition comprising the same |
| 07/14/2011 | WO2011028061A3 Novel bacteriophage and antibacterial composition comprising the same |
| 07/14/2011 | WO2011028059A3 Novel bacteriophage and antibacterial composition comprising the same |
| 07/14/2011 | WO2011028057A3 Novel bacteriophage and antibacterial composition comprising the same |
| 07/14/2011 | WO2011022071A3 Cardiac compositions |
| 07/14/2011 | WO2011022070A3 Perivascular stem cell composition for bone |
| 07/14/2011 | WO2011021832A3 Composition for preventing or treating a spinal cord injury |
| 07/14/2011 | WO2011020913A3 Cyclodepsipeptide antiviral compounds |
| 07/14/2011 | WO2011014883A3 Skin rejuvenation and wrinkle treatment by gingival fibroblast and its growth factor: activation of effect by hyluronic acid |
| 07/14/2011 | US20110173722 Novel insulin derivatives having an extremely delayed time-action profile |
| 07/14/2011 | US20110173715 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
| 07/14/2011 | US20110173711 eNos Mutations Useful for Gene Therapy and Therapeutic Screening |
| 07/14/2011 | US20110173707 System for the Determination of Molecules Altering the Function of Interferon, Method Therefor and Compounds Altering Interferon Activity |
| 07/14/2011 | US20110172704 Solder formulation and use in tissue welding |
| 07/14/2011 | US20110172581 Hemostatic compositions and uses therefor |
| 07/14/2011 | US20110172390 Protein-Proteophore Complexes |
| 07/14/2011 | US20110172213 Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer |
| 07/14/2011 | US20110172178 Beta-l-2' deoxynucleosides for the treatment of resistant hbv strains and combination therapies |
| 07/14/2011 | US20110172171 Taurine or taurine-like substances for the prevention of brain oedema |
| 07/14/2011 | US20110172170 Interferon-like protein zcyto21 |
| 07/14/2011 | US20110172169 Method of Detection of Nucleic Acids with a Specific Sequence Composition |
| 07/14/2011 | US20110172168 Ilt-2 (lir1) variants with increased affinity for mhc class i molecules |
| 07/14/2011 | US20110172167 Formulations of daptomycin |
| 07/14/2011 | US20110172166 Anionic polysaccharides functionalized by a hydrophobic acid derivative |
| 07/14/2011 | US20110172165 Modified linkers |
| 07/14/2011 | US20110172164 Bi-dentate compounds as kinase inhibitors |
| 07/14/2011 | US20110172163 Novel Protease Inhibitors |
| 07/14/2011 | US20110172162 Chemotherapy involving antisense oligonucleotides for preventing and/or treating pulmonary fibrosis |
| 07/14/2011 | US20110172161 Composition for therapeutic and cosmetic botulinum toxin |
| 07/14/2011 | US20110172160 Heat-stable, aqueous lactoferrin composition and its preparation and use |
| 07/14/2011 | US20110172159 Proteic acid polymer, production processes, use of proteic acid polymer, pharmaceutical composition and method of treatment |
| 07/14/2011 | US20110172158 Targets, methods, and reagents for diagnosis and treatment of schizophrenia |
| 07/14/2011 | US20110172157 Somatostatin analogues |
| 07/14/2011 | US20110172156 Methods and compositions for treating bleeding disorders |
| 07/14/2011 | US20110172155 Beta thymosin fragments |
| 07/14/2011 | US20110172154 Preventive and/or therapeutic and/or aggravation suppressing agent for human arthritis deformans |
| 07/14/2011 | US20110172153 Screening methods using g-protein coupled receptors and related compositions |
| 07/14/2011 | US20110172152 Treatment of short bowel syndrome patients with colon-in-continuity |
| 07/14/2011 | US20110172151 Derivatives of growth hormone and related proteins, and methods of use thereof |
| 07/14/2011 | US20110172150 Tissue regeneration method |
| 07/14/2011 | US20110172149 Method of Regulating Glucose Metabolism, and Reagents Related Thereto |
| 07/14/2011 | US20110172148 Periostin-induced pancreatic regeneration |
| 07/14/2011 | US20110172147 Neuropeptide-2 receptor (y-2r) agonists |
| 07/14/2011 | US20110172146 Growth hormone polypeptides and methods of making and using same |
| 07/14/2011 | US20110172145 Antimicrobial compounds |
| 07/14/2011 | US20110172144 Methods for increasing expression of serca2a in cardiac muscle |
| 07/14/2011 | US20110172143 Method of modulating cell survival and reagents useful for same |
| 07/14/2011 | US20110172142 Functional Food Paste |
| 07/14/2011 | US20110172141 Process for preparing microparticles |
| 07/14/2011 | US20110172140 Poly-Pegylated Protease Inhibitors |
| 07/14/2011 | US20110172139 Peptides whose uptake by cells is controllable |
| 07/14/2011 | US20110172114 Compositions and methods for the treatment of immune related diseases |
| 07/14/2011 | US20110171607 Biopulp |
| 07/14/2011 | US20110171453 Immunoneutral silk-fiber-based medical devices |
| 07/14/2011 | US20110171325 Systems and Methods for Treating Pain Using Brain Stimulation |
| 07/14/2011 | US20110171318 Methods and compositions for the prevention and treatment of kidney disease |
| 07/14/2011 | US20110171312 Modified therapeutic peptides, methods of their preparation and use |
| 07/14/2011 | US20110171311 Stable hydrogel compositions including additives |
| 07/14/2011 | US20110171310 Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use |
| 07/14/2011 | US20110171308 Ph-sensitive solid pharmaceutical composition for oral preparation and preparation method thereof |
| 07/14/2011 | US20110171305 Dehydrated hydrogel inclusion complex of a bioactive agent with flowable drug delivery system |
| 07/14/2011 | US20110171304 Injectable beta-hairpin peptide hydrogel that kills methicillin-resistant staphylococcus aureus |
| 07/14/2011 | US20110171294 Enzyme composition and application thereof in the treatment of pancreatic insufficiency |
| 07/14/2011 | US20110171292 Peptide compositions and methods of use |
| 07/14/2011 | US20110171289 Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis |
| 07/14/2011 | US20110171285 Design of Fibrinogen and Fibrinogen Derived Products with Reduced Bacterial Binding by Using Modified Sequences of Fibrinogen Chains |
| 07/14/2011 | US20110171283 Composition containing at least one nutrivite, at least one disinfecting or decontaminating, and/or at least one protease-inhibiting active compound and/or active compound complex |
| 07/14/2011 | US20110171272 Urological medical devices for release of prostatically beneficial therapeutic agents |
| 07/14/2011 | US20110171268 Uricase compositions and methods of use |
| 07/14/2011 | US20110171264 Protein Formulation |
| 07/14/2011 | US20110171248 Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines |